150 related articles for article (PubMed ID: 11304571)
1. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4.
Lassus H; Laitinen MP; Anttonen M; Heikinheimo M; Aaltonen LA; Ritvos O; Butzow R
Lab Invest; 2001 Apr; 81(4):517-26. PubMed ID: 11304571
[TBL] [Abstract][Full Text] [Related]
2. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
Lassus H; Salovaara R; Aaltonen LA; Butzow R
Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of 103 ovarian serous and mucinous tumors.
Vereczkey I; Serester O; Dobos J; Gallai M; Szakács O; Szentirmay Z; Tóth E
Pathol Oncol Res; 2011 Sep; 17(3):551-9. PubMed ID: 21136228
[TBL] [Abstract][Full Text] [Related]
4. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
5. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms.
Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM
Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616
[TBL] [Abstract][Full Text] [Related]
6. Genomic imbalances in ovarian borderline serous and mucinous tumors.
Hu J; Khanna V; Jones MM; Surti U
Cancer Genet Cytogenet; 2002 Nov; 139(1):18-23. PubMed ID: 12547152
[TBL] [Abstract][Full Text] [Related]
7. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
[TBL] [Abstract][Full Text] [Related]
8. Mutation of K-RAS protooncogene and loss of heterozygosity on 6q27 in serous and mucinous ovarian carcinomas.
Suzuki M; Saito S; Saga Y; Ohwada M; Sato I
Cancer Genet Cytogenet; 2000 Apr; 118(2):132-5. PubMed ID: 10748293
[TBL] [Abstract][Full Text] [Related]
9. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas].
Hong FZ; Wang B; Li HM; Liew CT
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544
[TBL] [Abstract][Full Text] [Related]
10. Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis.
Dimova I; Orsetti B; Negre V; Rouge C; Ursule L; Lasorsa L; Dimitrov R; Doganov N; Toncheva D; Theillet C
Tumori; 2009; 95(3):357-66. PubMed ID: 19688977
[TBL] [Abstract][Full Text] [Related]
11. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
[TBL] [Abstract][Full Text] [Related]
12. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
13. Parkin gene alterations in ovarian carcinoma from northern Indian population.
Mehdi SJ; Ali A; Rizvi MM
Pathol Oncol Res; 2011 Sep; 17(3):579-86. PubMed ID: 21221875
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
16. Alteration of BRCA-1 tumor suppressor gene expression in serous and mucinous ovarian neoplasms in the benign-borderline-malignant pathway.
Yousif HMA; Mohammed RAA
Curr Probl Cancer; 2019 Aug; 43(4):377-385. PubMed ID: 30446260
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation.
Garcia A; Bussaglia E; Machin P; Matias-Guiu X; Prat J
Int J Gynecol Pathol; 2000 Apr; 19(2):152-7. PubMed ID: 10782412
[TBL] [Abstract][Full Text] [Related]
18. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
19. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.
Tapper J; Bützow R; Wahlström T; Seppälä M; Knuutila S
Br J Cancer; 1997; 75(12):1782-7. PubMed ID: 9192982
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Expression of Anaplastic Lymphoma Kinase in Ovarian Carcinoma Independent of Gene Rearrangement.
Tang S; Yang F; Du X; Lu Y; Zhang L; Zhou X
Int J Gynecol Pathol; 2016 Jul; 35(4):337-47. PubMed ID: 27271776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
